Signal Bay Inc (SGBY) 0.0140 $SGBY Signal Bay Makes

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Signal Bay Inc (SGBY) 0.0140 $SGBY

Signal Bay Makes Strategic Acquisition in the $850M Cannabis Testing Market
ACCESSWIRE - Wed Sep 23, 8:20AM CDT
SEATTLE, WA / ACCESSWIRE / September 23, 2015 / Oregon has been on the forefront of the cannabis industry for many years. After legalizing medical marijuana back in 1998 and recreational marijuana last year, the state has been a pioneer when it comes to important issues like reprieve for prior crimes. Measure 91 promises to open up a $450 million market for the state by 2020, according to New Frontier Financials projections, creating jobs, raising tax revenue, and yielding opportunities for investors.
INSY: 25.65 (+0.64), GWPH: 87.75 (+0.45)

Signal Bay Inc. Completes Acquisition of Oregon Analytical Testing Laboratory
Business Wire - Mon Sep 21, 7:00AM CDT
Signal Bay Inc. (OTC:SGBY) is pleased to announce it has completed the acquisition of CannAlytical Research, an analytical testing laboratory in Bend, Oregon. Equipped with the latest high-performance liquid chromatography equipment, CannAlytical Research has been providing state-mandated compliance tests for licensed medical marijuana dispensaries since May 2014.

Signal Bay: Leveraging Experts to Build a Conglomerate
ACCESSWIRE - Wed Aug 05, 8:49AM CDT
SEATTLE, WA / ACCESSWIRE / August 5, 2015 / The U.S. cannabis industry could reach $35 billion in size by 2020, according to GreenWave Advisors, if all 50 states legalize the substance and the federal government ends prohibition. Within the rapidly growing industry, investors have a number of different options when deploying capital, ranging from hands-on plays like Latteno Food Corp.'s (OTC: LATF) stake in Los Angeles dispensaries to hands-off plays like CannLabs Inc.'s (OTC: CANL) testing facilities.
LNKD: 195.61 (-2.42)

Signal Bay Enters into a $1 Million Equity Purchase Agreement
Business Wire - Tue Aug 04, 7:00AM CDT
Signal Bay, Inc. (OTC: SGBY), a company focused on analytical testing, industry research, and management consulting for the cannabis and related ancillary businesses, announced that it has entered into a financing agreement with Kodiak Capital Group, LLC. The Company has agreed to file a registration statement with the U.S. Securities & Exchange Commission ("SEC" covering the shares that may be issued to Kodiak under this financing. After the SEC has declared the registration statement related to the transaction effective, the Company has the right at its sole discretion to sell common shares to Kodiak under the terms of the financing agreement. Proceeds from this transaction will be used to fund the continued development of the Company's strategy spanning the entire industry supply chain from seed to sale.

Signal Bay Announces the Launch of the Cannabis Consultant Marketplace
Business Wire - Thu Jul 30, 7:00AM CDT
Signal Bay Inc. (OTC: SGBY), a leading provider of research and expert consulting services to the legal cannabis industry, expands its practice through the launch of the Cannabis Consultant Marketplace (CCM), an industry-centric consulting Managed Marketplace. The CCM enables organizations to find and engage vetted, industry experts for short-term projects and long term engagements.

Company Profile for Signal Bay Inc.
Business Wire - Fri Jul 17, 9:40AM CDT
Signal Bay Inc., home of the Cannabis Consultant Marketplace, provides research and expert consulting services to the legalized cannabis industry. CANNAiQ, Signal Bay's information portal, provides current regulatory information, industry insights and current resources including the Medical Marijuana Desk Reference. Signal Bay Services provides advisory, agricultural and management services to licensed cannabis establishments.

Signal Bay, Inc. Announces Expansion of Cannabis Advisory Board
Business Wire - Thu Jul 16, 4:31AM CDT
Signal Bay, Inc. (OTC: SGBY), leading provider of research and expert consulting services to the legal cannabis industry, announces that it has entered into a strategic advisory agreement with Casey Houlihan. Mr. Houlihan is co-founder and executive director of the Oregon Retailers of Cannabis Association, is partner in two licensed Oregon Medical Marijuana Dispensaries and was field director for the Yes on 91 Campaign, the ballot measure which legalized recreational cannabis in the state of Oregon. Mr. Houlihan will join Electrum Partners founders, Leslie Bocskor and Gordon Katz on Signal Bay's Advisory Board.

Signal Bay Inc. Announces Engagement with Jim Fitzpatrick, Southern California Planner and Land Use Expert
Business Wire - Tue Jul 14, 8:30AM CDT
Signal Bay (OTC: SGBY) announces that it has engaged Solutioneers to lead efforts to obtain local municipality approval to operate a cannabis analytical testing facility in Southern California. Solutioneers, led by Jim Fitzpatrick, prior planning commissioner for the City of Costa Mesa in Orange County, California, provides compliance and land use services to cannabis firms.

Signal Bay Executes Strategic Partnership with Cannabis Benchmarks™
Filing Services Canada XHTML - Wed Jun 24, 8:01AM CDT


Signal Bay Executes Strategic Partnership with Cannabis Benchmarks(tm)
GlobeNewswire - Wed Jun 24, 8:00AM CDT
Signal Bay, Inc. (OTC: SGBY) and Cannabis Benchmarks(TM) a division of New Leaf Data Services, LLC have announced a partnership for Signal Bay to provide expertise in the area of primary industry data research.

Updated headline: The Comprehensive Guide to Medical Cannabis Medical Marijuana Desk Reference: by Alicia K. Wilbur PhD
GlobeNewswire - Thu Jun 18, 6:35AM CDT
Signal Bay Inc. (OTC: SGBY)

The Comprehensive Guide to Medical Cannabis Medical Marijuana Desk Reference: by Alicia K. Wilbur PhD
Filing Services Canada - Thu Jun 18, 5:02AM CDT
The Comprehensive Guide to Medical Cannabis Medical Marijuana Desk Reference: by Alicia K. Wilbur PhD Las Vegas, Nevada (FSCwire) - Signal Bay Inc. (OTC: SGBY) Esteemed author, research scientist, and lecturer, Alicia K. Wilbur, PhD, in partnership with Signal Bay Research, a wholly owned subsidiary of Signal Bay, Inc., has published a current-state snapshot of the scientifically documented benefits of medical cannabis. In this easy-to-use reference guide, Dr. Wilbur identified over 80 diseases and/or symptom complexes for which cannabis has been shown by scientific evidence to be of definitive human benefit. Signal Bay President, Lori J. Glauser stated, We are impressed by the level of attention and detail Dr. Wilbur put into this book. She has compiled over 800 medical studies that patients, caregivers and even medical professionals can reference as they become more knowledgeable and comfortable with the medicinal benefits of medical cannabis. http://cannaiq.com/wp-content/uploads/2015/01...rtened.png (http://cannaiq.com/wp-content/uploads/2015/01/FrontCover_shortened.png) The Medical Marijuana Desk Reference is the most comprehensive and up-to-date guide on the scientific research of Cannabis species for medical treatment. The MMDR compiles primary scientific studies on the efficacy of marijuana for both state-authorized and other, not yet authorized conditions in an easy-to-use format. David Snipper, MD writes in the foreword, For a patient or a caregiver with a family member facing chronic or critical illness, the cannabis novice, aficionado, physician, scientist, or otherwise, Dr. Wilburs Desk Reference is a user-friendly manual that I hope will find its way into the homes and offices of many folks who wish to have a more scientific view of the nature and value of this extraordinary plant. The Medical Marijuana Desk Reference can be purchased directly from Signal Bay Research at www.mmdr.us (http://www.mmdr.us). The site also provides a patient forum, where patients can discuss how they may use medical marijuana to treat their conditions. About Signal Bay, Inc. Signal Bay Inc., through its wholly owned subsidiaries Signal Bay Research, Inc. and Signal Bay Services, Inc. provides research, analysis, and consulting services to the medical marijuana industry. Signal Bay Research, in partnership with industry experts, provides comprehensive industry data and business intelligence for the legal cannabis industry. Signal Bay Services provides advisory, agricultural and management services to licensed medical marijuana establishments. Learn more at www.signalbayinc.com. Notice Regarding Forward-Looking Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Actual results could differ from those projected in any forward-looking statements due to numerous factors. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Contact: William Waldrop william@signalbayinc.com (888) 978-5066 To view this press release as a PDF file, click onto the following link: http://fscwire.com/sites/default/files/news_r...182015.pdf Source: Signal Bay Inc. (OTC Pink:SGBY) Maximum News Dissemination by FSCwire. http://www.fscwire.com Copyright(C)2015 Filing Services Canada Inc.

The Comprehensive Guide to Medical Cannabis edical Marijuana Desk Reference: by Alicia K. Wilbur PhD
GlobeNewswire - Thu Jun 18, 5:00AM CDT
Signal Bay Inc. (OTC: SGBY)

Signal Bay Inc. receives approval from Division of Public and Behavioral Health
Filing Services Canada XHTML - Mon May 11, 8:20AM CDT


Acquisition may Jump Start this Small Cap Medical Marijuana Player - Signal Bay Analyst Report by BrokerBank Securities, Inc.
PR Newswire - Mon May 11, 6:00AM CDT
Signal Bay, Inc. (OTCBB: SGBY) a provider of research, analysis, advisory services, and operating services to the medical marijuana industry, recently announced its intent to acquire a majority interest in an operating U.S. medical marijuana testing and research facility to carry out statewide requirements. The company added that it will retain the technical science and compliance team that have been operating the facility since 2014. The Letter of Intent is targeted to close by May 31, 2015.

Signal Bay Inc. to Acquire Cannabis Testing and Research Laboratory
Filing Services Canada - Fri May 08, 8:15AM CDT
Signal Bay Inc. to Acquire Cannabis Testing and Research Laboratory Las Vegas, Nevada (FSCwire) - Signal Bay Inc. (OTC:SGBY) is pleased to announce that is has entered into a Letter of Intent (LOI) to acquire a majority interest in an operating U.S. medical marijuana testing and research facility to carry out statewide requirements. The technical science and compliance team that have been operating the facility and serving the needs of their local customers since 2014 will be retained. "As our ongoing industry research delivers practical testing and research income opportunities, we are confident of the next step in our future" stated William Waldrop CEO of Signal Bay The LOI targeted to close by May 31, 2015. About Signal Bay, Inc. Signal Bay Inc., through its wholly owned subsidiaries Signal Bay Research, Inc. and Signal Bay Services, Inc. provides research, analysis, advisory services, and operating services to the medical marijuana industry. Signal Bay Research, in partnership with industry experts, provides comprehensive industry data and business intelligence for the legal cannabis industry. Signal Bay Services provides advisory, agricultural and management services to licensed medical marijuana establishments. SignalBayInc.com SignalBayResearch.com (702) 748-9944 Notice Regarding Forward-Looking Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Actual results could differ from those projected in any forward-looking statements due to numerous factors. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Contact: William Waldrop william@signalbayinc.com (702) 748-9944 To view this press release as a PDF file, click onto the following link: http://www.fscwire.com/sites/default/files/ne...082015.pdf Source: Signal Bay Inc. (OTC Pink:SGBY) Maximum News Dissemination by FSCwire. http://www.fscwire.com Copyright(C)2015 Filing Services Canada Inc.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BTQ's MIMIQ: A Quantum Leap for 35,000 Developers

Updated Category News Views 17

Breaking Barriers in Quantum Emulation If you think the quantum computing game is all about hardware, then you're missing half the picture. Enter BTQ Technologies, crash-landing into the scene by throwing open the doors of their MIMIQ emulator to a crowd of over 35,000 quantum developers through qBraid. This ain't just an upgrade—it's a seismic shift. More qubits, more...

Continue Reading
SoftwareOne Triumphs in 2026 GitHub Partner Awards

Updated Category News Views 55

SoftwareOne Nabs Prestigious GitHub Honor Outta nowhere, SoftwareOne's been lashed onto the center stage, bagging GitHub's Global Channel Sales Partner of the Year for 2026. This ain't just another shiny trophy on the shelf; it's a solid nod to their grit and strategy. Now, if good old GitHub says you're their top dog, you're obviously doing something right. Not bad for a...

Continue Reading
PBM Transparency Rule: Game Changer for 136M Americans

Updated Category News Views 23

Turning the Tide on Pharmacy Costs The world of pharmacy benefits is getting a long-overdue shake-up, courtesy of a new rule mandating transparency from the pharmacy benefit managers (PBMs). This ain't your everyday administrative tweak—it's a seismic shift for the 136 million Americans tied into employer-sponsored health plans. Thanks to the U.S. Department of Labor...

Continue Reading
Yale's $10M Inflammation Initiative: Future Health Impact

Updated Category News Views 0

Yale’s Inflammation Research: Beyond the Basics Inflammation. It’s the kind of battle your own body wages from within, and Yale School of Medicine’s fresh $10 million grant from the Blavatnik Family Foundation means they’re marching deeper into the trenches. This is not another academic exercise; it’s about digging out the roots of diseases that are tough to pin...

Continue Reading
TIOmarkets App Unveils Enhanced Trading Features

Updated Category News Views 32

Trading on the Go Takes a Leap Forward Pretty slick development from TIOmarkets, if I do say so myself. They've rolled out a major expansion of their mobile trading app, now packing some hefty features like Depth of Market and more granular order controls right from those little devices in our pockets. Quite the leap if you're one of those folks who can't keep your eyes...

Continue Reading
Data Breach at Lumara Bio: Privacy Lawsuits Loom

Updated Category News Views 217

Another Day, Another Data Breach It seems like you can’t throw a stone without hitting a data breach these days—and this time, it’s Lumara Bio USA’s turn under the spotlight. The Princeton-based oncology therapeutics outfit, part of Germany’s ITM Isotope Technologies, spilled some beans it never meant to. We're talking some pretty sensitive stuff here, folks....

Continue Reading
Equitable Bank Bumps Rates Amid Market Shuffle

Updated Category News Views 57

Equitable Bank Dials Up Its Prime Rate Equitable Bank's taken a step that every borrower and investor out there can't ignore: they've hiked their prime lending rate by 25 basis points, pushing it up to 4.70% from 4.45%. Now, any old-timer in the trading arena knows that when banks shift their rates, it's not just numbers on paper—it ripples across the landscape, from...

Continue Reading
Beta Bionics: Investors on Edge, Legal Moves Underway

Updated Category News Views 81

A Tumultuous Time for Beta Bionics Investors Trouble's brewing for those holding Beta Bionics, Inc. (NASDAQ: BBNX) shares. This isn't just market jitters—it's a full-blown legal tussle. The shareholder-rights law honchos at Johnson Fistel are sounding the alarms, and investors better heed their call before the clock strikes November 3, 2026. There's a class action...

Continue Reading
Bitcoin Mortgages: APX Ushers in New Canadian Era

Updated Category News Views 0

Bitcoin Meets Canadian Mortgages: A Game Changer? Here's a scenario you didn't see coming: Bitcoin, the digital darling of the new millennium, now backing Canadian mortgages. If that doesn't get your financial senses tingling, maybe you haven't been paying attention. APX Lending, a pioneer in digital-asset-backed lending, is kicking open the doors to a fresh financial...

Continue Reading
Quanta Services Reports Record Q3 2026 Earnings

Updated Category News Views 51

Quanta Services Smashes Q3 2026 Expectations If you're a stakeholder in Quanta Services, you'd probably be dancing in the aisles right now. This company just posted off-the-charts numbers for the third quarter of 2026. We're talking revenues of $12 billion—a staggering leap from $7.63 billion the same quarter last year. Explosive Earnings and Strong Backlog The star of...

Continue Reading

Top 5 Most Recently Viewed Articles

BullFrog AI's Direct Offering Could Elevate Growth Potential

Updated Category News Views 160

Bullfrog AI's Financial Moves to Propel Future Growth BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) is setting the stage for substantial growth with its latest financial initiatives. WallachBeth Capital announced that the company has entered into a definitive agreement for the sale of approximately 1,565,000 shares of common stock through a registered direct offering....

Continue Reading
Aclarion Strengthens Market Position with New UK Director

Updated Category News Views 138

New Leadership in the UK Market Aclarion, Inc. is excited to announce the appointment of Dan Isherwood as the new UK Commercial Director. This strategic hire marks a significant milestone for the company, enhancing its capacity to penetrate the UK healthcare market effectively. With a robust background in HealthTech, Isherwood is poised to help drive the utilization of...

Continue Reading
Navigating Travel Insurance Amidst Potential Government Shutdowns

Updated Category News Views 98

Navigating Travel Insurance Amidst Potential Government Shutdowns As uncertainties loom regarding potential government shutdowns, travelers find themselves questioning how these events might disrupt their plans. A looming government shutdown often leads to numerous challenges, including staffing shortages at key agencies such as the FAA and TSA. These essential services,...

Continue Reading
Immuthera's Advisory Board: Pioneering New Frontiers in Diabetes Care

Updated Category News Views 146

Immuthera's Scientific Advisory Board: Innovation at the Forefront Immuthera, a leading name in the field of cell therapies, is thrilled to introduce its newly assembled Scientific Advisory Board. This esteemed group includes renowned experts like Dr. Jay Skyler, Dr. Desmond Schatz, and Dr. Lawrence Steinman. Their collective expertise will drive innovative solutions in...

Continue Reading
Astroport and Orbit Fab Partner to Advance Lunar Exploration

Updated Category News Views 128

Astroport and Orbit Fab Team Up for Lunar Exploration Astroport Space Technologies, Inc., a leader in advanced space exploration solutions, and Orbit Fab, Inc., renowned for in-space refueling and resource utilization, have announced an exciting partnership aimed at accelerating lunar infrastructure development. This collaboration marks a pivotal moment in the quest for...

Continue Reading